{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:20:39Z","timestamp":1793830839512,"version":"4.6.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regenerative Therapy"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.reth.2022.04.004","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T23:25:05Z","timestamp":1651533905000},"page":"126-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Advanced Therapy medicinal products for autologous chondrocytes and comparison of regulatory systems in target countries"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1251-539X","authenticated-orcid":false,"given":"Jiwon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5693-1731","authenticated-orcid":false,"given":"Jaehong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1694-0940","authenticated-orcid":false,"given":"Seung-Yeon","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3525-8805","authenticated-orcid":false,"given":"Eunyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reth.2022.04.004_bib1","series-title":"World Preview","year":"2019"},{"key":"10.1016\/j.reth.2022.04.004_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.reth.2014.10.001","article-title":"Regulatory approval for autologous human cells and tissue products in the United States, the European Union, and Japan","volume":"1","author":"Yano","year":"2015","journal-title":"Regen Ther"},{"key":"10.1016\/j.reth.2022.04.004_bib3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00002281-200203000-00010","article-title":"Chondral injuries","volume":"14","author":"Sellards","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.reth.2022.04.004_bib4","unstructured":"Korean Knee Society home page. Available from:, http:\/\/www.koreaknee.or.kr\/general\/event\/event01.html."},{"key":"10.1016\/j.reth.2022.04.004_bib5","article-title":"(CAT) and the CAT scientific secretariat. Challenges with advanced therapy medicinal products and how to meet them","volume":"9","year":"2010","journal-title":"Nat Rev"},{"key":"10.1016\/j.reth.2022.04.004_bib6","first-page":"161","volume":"vol. 10","author":"Alkaya","year":"2020"},{"key":"10.1016\/j.reth.2022.04.004_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41536-018-0055-2","article-title":"Trends in clinical trials for articular cartilage repair by cell therapy","volume":"3","author":"Negoro","year":"2018","journal-title":"NPJ Regen Med"},{"key":"10.1016\/j.reth.2022.04.004_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1089\/ten.teb.2019.0315","article-title":"A\u00a0worldwide overview of regulatory frameworks for tissue-based products. termis 2020","volume":"26","author":"Oberweis","year":"2020","journal-title":"Tissue Eng Part B Rev"},{"key":"10.1016\/j.reth.2022.04.004_bib11","series-title":"Human medicines\/European public assessment reports for spherox\u24c7","year":"2017"},{"key":"10.1016\/j.reth.2022.04.004_bib12","unstructured":"Food and Drug Administration home page. Available from: URL, https:\/\/www.fda.gov\/vaccines-blood-biologics\/cellular-gene-therapy-products\/approved-cellular-and-gene-therapy-products."},{"key":"10.1016\/j.reth.2022.04.004_bib13","unstructured":"Pharmaceutical and medical device agency. Review reports: regenerative medical products for JACC\u24c7. Available from: URL, https:\/\/www.pmda.go.jp\/english\/review-services\/reviews\/approved-information\/0004.html."},{"key":"10.1016\/j.reth.2022.04.004_bib14","unstructured":"Therapeutic Goods Administration. ARTG for Chondrocytes_Chondrocytes \u2013T- Ortho-ACI. Available from: URL, https:\/\/search.tga.gov.au\/s\/search.html?collection=tgaartg&profile=record&meta_i=289402."},{"key":"10.1016\/j.reth.2022.04.004_bib15","unstructured":"Ministry of Food and Drug Safety home page. Available from: URL, https:\/\/nedrug.mfds.go.kr\/pbp\/CCBBB01\/getProductDetail?productSeq=202106181."},{"key":"10.1016\/j.reth.2022.04.004_bib16","unstructured":"Ministry of Food and Drug Safety home page. Available from: URL, https:\/\/nedrug.mfds.go.kr\/pbp\/CCBBB01\/getProductDetail?productSeq=202105509."},{"key":"10.1016\/j.reth.2022.04.004_bib17","unstructured":"Ministry of Food and Drug Safety. Approval review report for Condron\u24c7. Available from: URL, https:\/\/nedrug.mfds.go.kr\/pbp\/CCBAC02\/getProduct?totalPages=357&limit=10&searchYn=true&page=1&title=%EC%BD%98%EB%93%9C%EB%A1%A0&jdgmnResultInfoSeq=20210000177."},{"key":"10.1016\/j.reth.2022.04.004_bib18","unstructured":"Ministry of Food and Drug Safety. Approval review report for Cartilife\u24c7. Available from: URL, https:\/\/nedrug.mfds.go.kr\/pbp\/CCBAC02\/getItem?totalPages=1&limit=10&searchYn=true&page=1&title=%EC%B9%B4%ED%8B%B0%EB%9D%BC%EC%9D%B4%ED%94%84&jdgmnResultInfoSeq=20210000172."},{"issue":"6","key":"10.1016\/j.reth.2022.04.004_bib19","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/00006199-199211000-00013","article-title":"Standardization of the visual analog scale","volume":"41","author":"Cline","year":"1992","journal-title":"Nurs Res"},{"issue":"248","key":"10.1016\/j.reth.2022.04.004_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00003086-198911000-00004","article-title":"Rationale for the knee society clinical rating system","author":"Insall","year":"1989","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.reth.2022.04.004_bib21","series-title":"Matrix-induced autologous chondrocyte implantation versus microfracture in the treatment of cartilage defects of the knee: a 2-year randomised study","author":"Basad","year":"2010"},{"key":"10.1016\/j.reth.2022.04.004_bib22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00003086-200005000-00020","article-title":"Two-to 9-year outcome after autologous chondrocyte transplantation of the knee","volume":"374","author":"Peterson","year":"2000","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.reth.2022.04.004_bib23","year":"1997","journal-title":"CARTICEL\u24c7. Label."},{"key":"10.1016\/j.reth.2022.04.004_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/bioengineering6010022","article-title":"Regenerative medicine: a review of the evolution of autologous chondrocyte implantation (ACI) therapy","volume":"6","author":"Davies","year":"2019","journal-title":"Bioengineering"},{"key":"10.1016\/j.reth.2022.04.004_bib25","unstructured":"Orthocell Ltd home page, https:\/\/www.orthocell.com.au\/cartilage-regeneration."},{"key":"10.1016\/j.reth.2022.04.004_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-2474-11-103","article-title":"Gel-type autologous chondrocyte (ChondronTM) implantation for treatment of articular cartilage defects of the knee","volume":"11","author":"Choi","year":"2010","journal-title":"BMC Muscoskel Disord"},{"key":"10.1016\/j.reth.2022.04.004_bib27","volume":"vol. 25","year":"2018"},{"key":"10.1016\/j.reth.2022.04.004_bib28","unstructured":"Food and Drug Administration. PDUFA reauthorization performance goals and procedures fiscal years 2018 through 2022."},{"key":"10.1016\/j.reth.2022.04.004_bib29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s40778-015-0012-6","article-title":"Regulatory landscape of regenerative medicine in Japan","volume":"1","author":"Azuma","year":"2015","journal-title":"Curr Stem Cell Rep"},{"key":"10.1016\/j.reth.2022.04.004_bib30","volume":"30","year":"2012"},{"key":"10.1016\/j.reth.2022.04.004_bib31","unstructured":"Ministry of Food and Drug Safety. Understanding of drug product approval and review procedures [in Korean]."},{"key":"10.1016\/j.reth.2022.04.004_bib32","series-title":"Autologous human cells and tissues products regulation, Australian Regulatory Guidelines for Biologicals (ARGB)","year":"2019"},{"key":"10.1016\/j.reth.2022.04.004_bib33","first-page":"842","volume":"21","author":"Korpershoek","year":"2020","journal-title":"BMC (Biomed Chromatogr)"},{"issue":"268","key":"10.1016\/j.reth.2022.04.004_bib34","first-page":"279","article-title":"The repair of full-thickness articular cartilage defects: immune responses to reparative tissue formed by allogenic growth plate chondrocyte implants","author":"Kawabe","year":"1991","journal-title":"Clin Orthop"},{"key":"10.1016\/j.reth.2022.04.004_bib35","volume":"28","year":"1996"},{"key":"10.1016\/j.reth.2022.04.004_bib36","volume":"13","year":"2016"},{"key":"10.1016\/j.reth.2022.04.004_bib37","series-title":"Procedure closure EU manufacturing site","year":"2014"},{"key":"10.1016\/j.reth.2022.04.004_bib38","series-title":"Reflection paper vitro-cultured chondrocyte containing products cartilage repair knee","year":"2010"},{"key":"10.1016\/j.reth.2022.04.004_bib39","series-title":"Guidance for industry: preparation of IDEs and INDs for products intended to repair or replace knee cartilage","year":"2011"},{"key":"10.1016\/j.reth.2022.04.004_bib40","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.reth.2015.06.003","article-title":"Non-clinical assessment design of autologous chondrocyte implantation products","volume":"1","author":"Ikawa","year":"2015","journal-title":"Regen Ther"},{"issue":"2","key":"10.1016\/j.reth.2022.04.004_bib41","article-title":"Long-term durability of autologous chondrocyte implantation","volume":"38","author":"Bruce Moseley","year":"2010","journal-title":"Am J Sports Med"},{"key":"10.1016\/j.reth.2022.04.004_bib42","unstructured":"EMA Medicines under additional monitoring. Available from: URL: https:\/\/www.ema.europa.eu\/en\/human-regulatory\/post-authorisation\/pharmacovigilance\/medicines-under-additional-monitoring#what-the-black-triangle-means-section."}],"container-title":["Regenerative Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320422000323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320422000323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:38:22Z","timestamp":1762450702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352320422000323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":40,"alternative-id":["S2352320422000323"],"URL":"https:\/\/doi.org\/10.1016\/j.reth.2022.04.004","relation":{},"ISSN":["2352-3204"],"issn-type":[{"value":"2352-3204","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced Therapy medicinal products for autologous chondrocytes and comparison of regulatory systems in target countries","name":"articletitle","label":"Article Title"},{"value":"Regenerative Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reth.2022.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}